ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Metformin Suppresses the Progress of Diabetes-Accelerated Atherosclerosis by Inhibition of Vascular Smooth Muscle Cell Migration Through AMPK-Pdlim5 Pathway

Yan, Yi; Li, Ting; Li, Zhonghao; He, Mingyuan; Wang, Dejiang; Xu, Yingyi; Yang, Xuewen; Bai, Yuanyuan; Lao, Yi; Zhang, Zhiyong*; Wu, Wei*广州医学院; 南方医科大学; 中山大学
Frontiers in Cardiovascular Medicine2021-7-23DOI: 10.3389/fcvm.2021.690627
18被引7阅读
引用收藏
分享

摘要

Backgrounds: Our previous work revealed that AMP-activated protein kinase (AMPK) activation inhibits vascular smooth muscle cell migration in vitro by phosphorylating PDZ and LIM domain 5 (Pdlim5). As metformin is an AMPK activator, we used a mouse vascular smooth muscle cell (VSMC) line and a Myh11-cre-EGFP mice to investigate whether metformin could inhibit the migration of VSMCs in vitro and in a wire-injury model in vivo. It is recognized that VSMCs contribute to the major composition of atherosclerotic plaques. In order to investigate whether the AMPK-Pdlim5 pathway is involved in the protective function of metformin against atherosclerosis, we utilized ApoE(-/-) male mice to investigate whether metformin could suppress diabetes-accelerated atherosclerosis by inhibition of VSMC migration via the AMPK-Pdlim5 pathway. Methods: The mouse VSMC cell line was exogenously transfected wild type, phosphomimetic, or unphosphorylatable Pdlim5 mutant before metformin exposure. Myh11-cre-EGFP mice were treated with saline solution or metformin after these were subjected to wire injury in the carotid artery to study whether metformin could inhibit the migration of medial VSMCs into the neo-intima. In order to investigate whether the AMPK-Pdlim5 pathway is involved in the protective function of metformin against atherosclerosis, ApoE(-/-) male mice were divided randomly into control, streptozocin (STZ), and high-fat diet (HFD)-induced diabetes mellitus; STZ+HFD together with metformin or Pdlim5 mutant carried the adenovirus treatment groups. Results: It was found that metformin could induce the phosphorylation of Pdlim5 and inhibit cell migration as a result. The exogenous expression of phosphomimetic S177D-Pdlim5 inhibits lamellipodia formation and migration in VSMCs. It was also demonstrated that VSMCs contribute to the major composition of injury-induced neointimal lesions, while metformin could alleviate the occlusion of the carotid artery. The data of ApoE(-/-) mice showed that increased plasma lipids and aggravated vascular smooth muscle cell infiltration into the atherosclerotic lesion in diabetic mice were observed Metformin alleviated diabetes-induced metabolic disorders and atherosclerosis and also reduced VSMC infiltration in atherosclerotic plaques, while the Pdlim5 phospho-abolished mutant that carried adenovirus S177A-Pdlim5 undermines the protective function of metformin. Conclusions: The activation of the AMPK-Pdlim5 pathway by metformin could interrupt the migratory machine of VSMCs and inhibit cell migration in vitro and in vivo. The maintenance of AMPK activity by metformin is beneficial for suppressing diabetes-accelerated atherosclerosis.

学科与关键词

关键词
metforminPdlim5AMPKdiabetesvascular smooth cells
相关
加载中…
  • Metformin attenuates carotid neointimal hyperplasia by modulating the vascular smooth muscle cell phenotype transformation through upregulation of TET2, Nur77 and calponin
    Lin, Hao; Cheng, Shuo; Yuan, Zhichao; Yan, Zhiqiang; Zhang, Jifa*Archives of Biological Sciences, 2021, 73(1): 135-144.
  • 二甲双胍通过调控血管平滑肌肌动蛋白骨架系统抑制小鼠动脉粥样硬化形成
    李挺; 何铭垣; 李忠豪; 王德奖; 徐颖怡; 吴炜; 燕翼南方医科大学学报, 2019, (11): 1357-1363.
  • Liraglutide Alleviates Diabetic Atherosclerosis through Regulating Calcification of Vascular Smooth Muscle Cells
    Shi, Li-Li; Hao, Ming; Jin, Zhou-Yun; Peng, Gui-Fang; Tang, Ying-Ying*; Kuang, Hong-Yu*DISEASE MARKERS, 2022, 2022: 5013622.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cardiovascular Medicine
发表日期
2021-07-23
卷期
第 8 卷
页码
690627
DOI
10.3389/fcvm.2021.690627
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81870320, 81600349]; State Key Laboratory of Organ Failure Research [G818NF0029]; Guangzhou Science and Technology Innovation Committee Fund [201804010008]; Featured Clinical Technique of Guangzhou [20190337]

作者

  • Y

    Yan, Yi (第一作者)

    guangzhou med univ · southern med univ

  • L

    Li, Ting

    guangzhou med univ · southern med univ

查看全部 11 位作者收起作者
  • L

    Li, Zhonghao

    southern med univ

  • H

    He, Mingyuan

    guangzhou med univ · southern med univ

  • W

    Wang, Dejiang

    guangzhou med univ

  • X

    Xu, Yingyi

    guangzhou med univ

  • Y

    Yang, Xuewen

    guangzhou med univ

  • B

    Bai, Yuanyuan

  • L

    Lao, Yi

    sun yat sen univ

  • Z

    Zhang, Zhiyong (通讯)

    guangzhou med univ

  • W

    Wu, Wei (通讯)

    guangzhou med univ · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417